Amicus Therapeutics (FOLD)

• Market cap: $2.96B
• 1 day: 1.8%
• 5 days: 2.79%
• 1 month: 13.63%
• 3 months: 29.42%
• 6 months: 49.38%
• Year to date: 3.01%
• 1 year: -0.72%
• 5 years: -57%
• 10 years: -7.52%
• Sector: Healthcare
• Industry: Biotechnology

About: Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

Employees: 499